Literature DB >> 25969484

Lessons from two cases: is Fabry disease the correct diagnosis?

Ertugrul Kiykim1, Cigdem Ayse Aktuglu Zeybek1, Tanyel Zubarioglu1, Ahmet Aydin1.   

Abstract

Fabry disease (FD) is an X linked inherited lysosomal storage disorder with complex multisystem involvement; it is caused by deficiency of the lysosomal enzyme α-galactosidase. Deficient enzyme activity leads to a wide spectrum of clinical manifestations consisting of dermatological, ophthalmological, cardiovascular, and urinary and central nervous system findings. As a result, FD should be considered in the differential diagnosis of many systemic diseases. Diagnosis of FD can arise from careful clinical and instrumental investigations, together with family history data and accurate interpretation of genetic and enzymatic analyses. Lack of knowledge on clinical findings of the disease and inept investigation methods unfortunately result in erroneous diagnosis. We present two patients who were referred to our clinic with a suspicion of ED and finally diagnosed as glycogen storage disorder type III and ornithine transcarbamylase deficiency, respectively. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25969484      PMCID: PMC4434327          DOI: 10.1136/bcr-2014-208150

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Considering Fabry, but Diagnosing MPS I: Difficulties in the Diagnostic Process.

Authors:  E J Langereis; I E T van den Berg; D J J Halley; B J H M Poorthuis; F M Vaz; J H J Wokke; G E Linthorst
Journal:  JIMD Rep       Date:  2012-10-30

2.  Misdiagnosis in Fabry disease.

Authors:  Cintia L Marchesoni; Norma Roa; Ana María Pardal; Pablo Neumann; Guillermo Cáceres; Pablo Martínez; Isaac Kisinovsky; Silvia Bianchi; Ana Lía Tarabuso; Ricardo C Reisin
Journal:  J Pediatr       Date:  2010-05       Impact factor: 4.406

3.  Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease.

Authors:  C Zizzo; P Colomba; G Albeggiani; R Gallizzi; F Iemolo; D Nuzzo; S Vasto; C Caruso; G Duro
Journal:  Clin Genet       Date:  2012-08-20       Impact factor: 4.438

Review 4.  Fabry's disease.

Authors:  Yuri A Zarate; Robert J Hopkin
Journal:  Lancet       Date:  2008-10-18       Impact factor: 79.321

5.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

6.  Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion.

Authors:  G E Linthorst; M A De Rie; K H Tjiam; J M F G Aerts; K P Dingemans; C E M Hollak
Journal:  Br J Dermatol       Date:  2004-03       Impact factor: 9.302

7.  Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.

Authors:  C M Eng; J Fletcher; W R Wilcox; S Waldek; C R Scott; D O Sillence; F Breunig; J Charrow; D P Germain; K Nicholls; M Banikazemi
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.